Good morning, everyone. Nice to see you again. A sunny day is unfolding here on the Pharmalot corporate campus, where we are happily quaffing our mandatory cup of stimulation. This will be an especially busy day as we must break for a personal matter, but we will endeavor, nonethless, to hunt about for interesting items. Meanwhile, we would like to remind you that we are hosting a webinar on requirements for disclosing payments to physicians (look here). See you soon...
Sanofi-Aventis To Buy Genzyme For $20 Billion (Bloomberg News)
Sanofi-Aventis Will Withdraw Anzement From Five Countries (Dow Jones)
Merck No Longer Has Buyer For Dutch R&D Unit (Reuters)
Takeda Strikes Deal With Covance And Quintiles (Outsourcing Pharma)
Generic Drugmakers To Support FDA User Fees (Wall Street Journal)
Astellas Pulls Japan Filng For Oral Factor Xa Inhibitor (Pharma Times)
Ligand Pharms Reports Smaller Quarterly Profit (Associated Press)
Actelion Gets Takeover Reprieve With Delay In Drug Data (Reuters)
Daiichi Sankyo Buys Its First US Manufacturing Plant (InPharma-Technologist)
Pharma Manufacturing In Minnesota Grows Rapidly (InPharma-Technologist)